MarketCap
Facebook
X
Telegram
Calumet Specialty Products Partners, L.P. Financial Ratios 2023-2008 | CLMT
Brief overview of Calumet Specialty Products Partners, L.P.'s valuation and returns
Ratios are assessed across five available annual reports in the 2011–2023 interval.
The latest available valuation ratios are P/E 25.92x (median 13.01x), EV/EBITDA 10.23x (median 18.77x), P/S 0.3x (median 0.28x). On average, this basket is 99.2% above its own five-year medians. The market is pricing in elevated future expectations.
Earnings yield calculated as 1/P/E is about 3.9%, showing current profit per unit of share price.
The latest available business-quality ratios are ROE -9.8%, ROA 1.7%, ROCE -54.5%. Returns below zero mean resources are not producing positive profit. Recovery in operating results is the main reference point.
PEG of 0.15x shows valuation is not outpacing embedded growth. The conclusion depends on earnings durability.
The cash conversion cycle remains near its former level at 30.2 days after 29.3 days.
Overall picture
Calumet Specialty Products Partners, L.P. combines weak profitability with valuation above its historical norm, leaving limited cushion.
Annual Financial Ratios Calumet Specialty Products Partners, L.P.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
25.9 | -7.7 | -4.0 | -1.6 | -6.6 | 9.5 | -5.8 | -0.9 | -10.2 | -11.8 | 391.4 | 5.9 | 13.0 | 75.0 | - | - |
P/S |
0.3 | 0.3 | 0.3 | 0.1 | 0.1 | 0.2 | 0.2 | 0.1 | 0.4 | 0.2 | 0.3 | 0.3 | 0.2 | - | - | - |
EPS |
0.6 | -2.1 | -3.2 | -1.9 | -0.6 | 0.2 | -1.3 | -4.2 | -2.0 | -1.8 | -0.2 | 3.5 | 1.0 | 0.5 | 1.9 | - |
EV (Enterprise Value) |
4.23 B | 4.32 B | 3.52 B | 2.07 B | 2.1 B | 2.04 B | 3 B | 2.81 B | 3.76 B | 3.59 B | 2.87 B | 2.54 B | 1.56 B | 1.87 B | -49 K | -48 K |
EBITDA per Share |
5.17 | 2.9 | 0.28 | 0.42 | 2.38 | 3.09 | 4.02 | 1.96 | 3.68 | 2.66 | 3.08 | 6.79 | 4.42 | 3.73 | - | - |
EV/EBITDA |
10.2 | 18.8 | 159.2 | 62.4 | 11.3 | 8.5 | 9.6 | 18.5 | 13.4 | 19.4 | 13.7 | 6.7 | 8.3 | 14.2 | -0.0 | - |
PEG |
0.15 | -0.05 | 0.35 | 0.12 | -0.65 | 0.8 | -1.01 | 0.2 | -1.21 | 0.01 | -5795515.09 | 0.03 | 0.0 | - | - | - |
P/B |
-5.1 | -4.6 | -2.7 | -1.9 | 13.2 | 2.6 | 5.0 | 1.4 | 2.4 | 1.6 | 1.3 | 1.4 | 0.8 | 3.1 | - | - |
P/CF |
-83.7 | 13.2 | -23.7 | 3.9 | 1.5 | 2.3 | -22.6 | 75.5 | 3.8 | 5.8 | 35.0 | 3.2 | 8.8 | 9.3 | - | - |
ROE % |
-9.81 | 32.50 | 67.54 | 115.86 | -201.85 | 27.55 | -86.57 | -150.25 | -23.08 | -13.85 | 0.33 | 23.12 | 5.90 | 4.19 | 12.73 | - |
ROA % |
1.75 | -6.32 | -12.22 | -8.24 | -2.35 | 0.87 | -3.86 | -12.06 | -4.73 | -3.64 | 0.13 | 9.13 | 2.48 | 1.64 | - | - |
ROCE % |
-54.50 | -24.73 | 22.23 | 55.91 | 5.90 | 7.35 | 8.96 | -0.01 | 6.78 | 1.82 | 4.19 | 16.08 | 9.33 | 17.95 | 13.88 | - |
Current Ratio |
0.9 | 0.9 | 0.8 | 0.9 | 1.0 | 1.0 | 1.0 | 1.1 | 1.3 | 1.4 | 1.7 | 1.7 | 1.7 | 1.6 | - | - |
DSO |
21.7 | 18.0 | 21.4 | 27.4 | 20.4 | 118.8 | 27.1 | 21.8 | 26.0 | 19.3 | 16.5 | 17.2 | 21.5 | - | - | - |
DIO |
45.9 | 34.7 | 35.3 | 46.1 | 35.1 | 35.7 | 37.6 | 43.9 | 41.3 | 35.6 | 41.3 | 48.8 | 63.5 | - | - | - |
DPO |
37.4 | 31.3 | 29.2 | 34.5 | 26.2 | 28.8 | 31.2 | 35.0 | 34.0 | 29.1 | 25.9 | 29.4 | 40.0 | - | - | - |
Operating Cycle |
67.6 | 52.7 | 56.7 | 73.5 | 55.5 | 154.5 | 64.7 | 65.7 | 67.4 | 54.9 | 57.8 | 66.0 | 85.0 | - | - | - |
Cash Conversion Cycle |
30.2 | 21.4 | 27.6 | 39.0 | 29.3 | 125.7 | 33.5 | 30.7 | 33.3 | 25.8 | 31.9 | 36.6 | 45.1 | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Calumet Specialty Products Partners, L.P.
| 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.51 | 1.26 | -0.23 | 0.23 | - | 0.19 | -0.19 | - | - | 0.64 | -0.97 | -1.82 | - | -0.7 | 0.05 | -0.18 | -0.48 | -0.06 | -0.21 | 0.2 | 0.23 | -0.21 | -0.65 | -0.06 | -1.06 | -0.3 | 0.12 | -0.08 | -1.01 | -0.42 | -1.89 | -0.87 | -1.56 | -0.68 | -0.02 | 0.27 | -0.95 | 0.08 | -0.17 | -0.76 | -0.27 | -0.54 | 0.05 | 0.67 | 0.73 | 0.69 | 1.14 | 0.97 | - | 0.46 | -0.19 | 0.11 |
EBITDA per Share |
1.02 | 3.2 | 0.83 | 1.01 | - | 1.41 | 1.59 | 0.16 | - | 1.57 | -0.05 | -0.96 | - | 0.61 | 0.96 | 0.03 | - | 1.48 | 0.77 | 0.79 | - | 1.42 | 1.32 | 0.91 | - | 2.13 | 1.72 | 0.94 | - | 1.77 | 1.04 | 0.26 | - | 1.54 | 2.04 | 1.46 | - | 2.33 | 0.79 | 0.94 | - | 0.99 | 1.24 | 1.33 | - | 2.19 | 1.85 K | 1.06 K | - | 1.76 | 1.01 | 0.7 |
ROE % |
-17.24 | -28.46 | -2.25 | 14.97 | 20.42 | 3.27 | 28.93 | 79.15 | 58.56 | 183.78 | 233.96 | 5.96 | -47.46 | -226.17 | -358.72 | -416.78 | -191.43 | 14.83 | -10.07 | -62.96 | -86.76 | -184.04 | -163.52 | -81.30 | -80.05 | -46.72 | -46.37 | -95.27 | -106.51 | -89.46 | -84.51 | -39.60 | -22.92 | -11.42 | -4.02 | -5.18 | -12.68 | -6.30 | -10.18 | -8.70 | 0.60 | 7.19 | 15.08 | 21.92 | 25.93 | 24.48 | 22.17 | 13.67 | 5.90 | 2.69 | -1.05 | 0.58 |
ROA % |
2.53 | 4.66 | 0.34 | -3.35 | -4.39 | -1.58 | -6.45 | -13.62 | -9.27 | -12.38 | -14.99 | -11.50 | -3.68 | -5.76 | -2.87 | -3.82 | -2.33 | 0.62 | 0.07 | -1.59 | -2.49 | -6.47 | -6.55 | -3.79 | -3.83 | -3.64 | -3.98 | -9.41 | -11.44 | -12.49 | -12.90 | -7.74 | -4.78 | -2.87 | -1.00 | -1.33 | -3.58 | -2.10 | -3.70 | -3.15 | 0.24 | 2.84 | 6.05 | 8.87 | 9.92 | 9.44 | 8.68 | 5.13 | 2.48 | 1.13 | -0.44 | 0.24 |
ROCE % |
-66.95 | -77.69 | -50.12 | -42.12 | -33.91 | -64.98 | -37.86 | 21.19 | 17.46 | 86.21 | 327.38 | -25.00 | -64.02 | -10.83 | -72.58 | -242.19 | 100.67 | 142.86 | 155.14 | 183.92 | 143.44 | 160.80 | 141.61 | 91.05 | 55.26 | 58.63 | 40.48 | 13.56 | -1.35 | -0.09 | 6.15 | 14.25 | 18.17 | 24.67 | 22.33 | 16.24 | 8.93 | 7.35 | 2.99 | 9.20 | 5.68 | 17.33 | 27.81 | 31.31 | 26.18 | 33.93 | 25.49 | 18.15 | 12.53 | 7.76 | 3.21 | 1.56 |
Current Ratio |
0.9 | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | 0.8 | 0.8 | 0.8 | 0.9 | 0.8 | 0.9 | 0.9 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.2 | 1.3 | 1.3 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.6 | 1.8 | 1.9 | 1.7 | 1.6 | 1.6 | 1.7 | 1.5 | 1.7 | 1.7 | 1.7 | 1.7 |
DSO |
26.1 | 21.4 | 23.1 | 22.4 | - | 26.1 | 21.8 | 21.7 | - | 23.2 | 24.1 | 26.7 | - | 25.6 | 34.7 | 23.9 | 24.5 | 24.6 | 26.7 | 24.9 | 25.8 | 27.9 | 28.1 | 38.6 | 35.9 | 28.1 | 25.3 | 23.2 | - | -83691.5 | -3221.4 | -1816.0 | - | -784.8 | -3509.8 | -6797.1 | - | -41961.3 | -38899.9 | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
41.9 | 45.6 | 43.1 | 46.2 | - | 32.4 | 23.6 | 28.4 | - | 36.0 | 31.6 | 36.4 | - | 41.1 | 58.0 | 36.8 | - | 32.5 | 33.3 | 36.7 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
32.6 | 31.9 | 32.4 | 40.6 | - | 41.0 | 31.7 | 30.7 | - | 28.7 | 24.9 | 27.2 | - | 27.9 | 40.0 | 27.8 | - | 29.4 | 28.3 | 28.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
67.9 | 67.0 | 66.2 | 68.5 | - | 29.4 | 21.8 | 50.2 | - | 59.2 | 55.6 | 63.1 | - | 66.7 | 90.4 | 58.9 | 21.4 | 51.4 | 53.0 | 57.5 | 21.3 | 18.9 | 19.1 | 33.6 | 36.6 | 31.5 | 33.4 | 28.8 | - | -72604.6 | -3067.8 | -1847.2 | - | -557.3 | -2344.7 | -5682.9 | - | -31919.2 | -31919.2 | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
35.3 | 35.1 | 33.8 | 28.0 | - | 9.4 | 7.0 | 19.5 | - | 30.5 | 30.8 | 35.9 | - | 37.0 | 48.4 | 31.0 | 21.4 | 25.5 | 26.4 | 30.0 | 21.3 | 18.9 | 19.1 | 33.6 | 36.6 | 31.5 | 33.4 | 28.8 | - | -72604.6 | -3067.8 | -1847.2 | - | -557.3 | -2344.7 | -5682.9 | - | -31919.2 | -31919.2 | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Multiples are an important financial analysis tool for the company Calumet Specialty Products Partners, L.P., allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.
Advantages of Using Financial Ratios- Simplified Data Analysis
Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition. - Comparability Between Companies
Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations. - Identification of Trends and Issues
Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks. - Decision Support
Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions. - Accelerated Assessment of Investment Attractiveness
Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.
Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.
Canada
USA
Russia
Indonesia
China
